Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

YCBD - cbdMD, Inc.

IEX Last Trade
0.5
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:19:56 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.51%

PREVIOUS CLOSE
CHG
CHG%
$0.50
-0.16
0.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 8%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-18.00%
1 Month
-21.82%
3 Months
-21.79%
6 Months
-40.98%
1 Year
-47.41%
2 Year
-96.80%
Key data
Stock price
$0.50
P/E Ratio 
-0.09
DAY RANGE
$0.34 - $0.50
EPS 
-$7.47
52 WEEK RANGE
$0.37 - $1.73
52 WEEK CHANGE
-$47.41
MARKET CAP 
2.047 M
YIELD 
N/A
SHARES OUTSTANDING 
3.763 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,068,543
AVERAGE 30 VOLUME 
$791,149
Company detail
CEO: Martin A. Sumichrast
Region: US
Website: cbdmd.com
Employees: 90
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. Its products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It has a research partnership with the University of Mississippi to identify novel cannabinoids.

Recent news